Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Diabetes & Endocrinology Webinars & Conferences

Europe & UK
Asia Pacific & Middle East

Herbal Diabetes 2023

About Conference

We are pleased to announce the start of the "28th International Conference on Diabetes, Endocrinology, and Healthcare," which will be held in Singapore on November 27-28, 2023 on the theme “Innovation in diabetes, the most cutting-edge technologies, and the latest research “. We invite all leading researchers, students, and delegates to attend Herbal Diabetes 2023 to participate in valuable scientific discussions and contribute to future innovations in medicine and polygenic disorder.
Join leading experts at this live event to learn about the state of diabetes care in 2023, as well as the most recent advances in research and treatment of complications.

Diabetes currently affects 138.2 million people in Asia, with the number expected to rise to 201.8 million by 2035

This conference will provide information on how the pandemic has affected Type 2 diabetes care, as well as the causal links between Covid and diabetes, the latest data on prevention and remission, and what the future holds for the treatment of complications in secondary care.

During this event you will:
  • Understand how Covid has changed the landscape of how Type-2 diabetes care is delivered 
  • Learn the latest information about the causal links between Covid and diabetes 
  • Explore the latest data on prevention and remission in the UK 
  • Gain updates on what’s new in in-patient care of diabetes 
  • Understand the latest developments in the research and treatment of a range of complications 
  • A live stream is also available for this event. Click here to register for the live stream.
Target Audience:
Endocrinologists | Diabetologists | Gynaecologist | Neurologists | Ophthalmologists | Oncologists | Physicians | Nutritionists/Dieticians | Diabetes Health Professionals | Medical faculties | Academic researchers | Research Institutes | Endocrinology Societies & Associations | Diabetes Societies & Associations | Obesity Societies & Associations | Pharmaceutical corporations | Researchers | Endocrinology, polygenic disorder & Metabolism Associations and Societies | Business Entrepreneurs | Training Institutes | Manufacturing Medical Devices corporations

Benefits of Attending

Benefits of Attending

  • Exchange ideas and a system with diabetologistsendocrinologists, polygenic disorder analysts, specialist clinicians, polygenic disorder and medicine consultants, and scientists from over forty countries
  • Discuss cooperative approaches to deliver quality activities throughout the study of polygenic disorder and medicine and therefore the drawback and treatment of polygenic disorder
  • Participants will increase guides' access to associate assembly centre of individuals from consultants and leaders and might broaden perception through rating and management of systems throughout conferences
  • Learn and quote vital news and challenges with huge speakers.
  • With introductions, governance dialogues, panel discussions and workshops, we tend to cowl each topic from begin to complete, from large-scale world problems to methodologies to strategic problems.

Diabetes Conference | Endocrinology Congress | Healthcare Meetings | Endocrinology Meetup | Pharma Conference Pharmaceutical Conference | Therapeutic Substance | Top Diabetes Conference | Diabetes Congress |  American Diabetes Association | Annual Clinical Conference on Diabetes

Market Analysis

Global Diabetes Market 

Global Diabetes Market: is expected to grow at a CAGR of 7.6% for the forecast period of 2018-2023. The market is segmented on the basis of diabetes type, drug class, and diabetic devices. Devices for diabetics include blood glucose meters and insulin delivery devices. The blood glucose meter market will have the largest market share compared to insulin delivery systems such as syringes and pen injectors. Continuous blood glucose monitoring systems will see the fastest growth in the market.

 The United States alone spends 11% of its health care expenditures on diabetes. India and China are most affected by diabetes with more than 120 million patients. The majority of diabetes patients are undiagnosed or do not have basic treatment. Some of the major manufacturers are trying to develop an artificial pancreas. Currently, CGMS devices are used with insulin pumps as a secondary prototype for the artificial pancreas. The artificial pancreas is expected to be ready for commercialization within the next decade.

Global Digital Diabetes/Management Market :

Expected to grow at a CAGR of 21.7% from 2018 to $12.03 billion by 2025. Increasing numbers of diabetes patients, increasing smartphone penetration, technological advancements in diabetes devices, and increasing funding for diabetes are the important factors in the growth of this market.

Based on The global digital diabetes management market is projected to reach $19.9 billion by 2024, up from $6.8 billion in 2019, at a CAGR of 23.8%.The growth of this market is mainly due to the increasing prevalence of diabetes, the increasing focus on the development and adoption of a digital platform for diabetes and technological progress.

Global Human Insulin Market:

Market Value Global Human Insulin is expected to register a CAGR of 8.8% over the 2018-2023 period, reflecting an increasing number of diabetes patients, a growing geriatric population, technological advancements in insulin delivery devices and increasing exposure of population for risk factors leading to diabetes.

Based on product, the human insulin market is divided into HI drugs and delivery devices. HI drugs had the largest market share in 2017, accounting for 79.5%, due to the high prevalence of diabetes, increased research and development (R&D) activities for drug discovery and development, growing market demand for HI analogues and increasing geriatric population. HI products are used in the treatment of type II diabetes, type I diabetes.

We provide the participants with different modes or ways to participate as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. The mode of participation is webinar through PowerPoint Presentation/ Video Presentation.

Keynote speaker: 45-50 minutes
Speaker (oral presentation): 25-30 minutes (only one person can present)
Speaker (workshop): 45-50 minutes (more than 1 can present)
Speaker (special session): 45-50 minutes (more than 1 can present)
Speaker (symposium): more than 45 minutes (more than 1 can present)
Delegate(only registration): will have access to all the sessions with all the benefits of registration
Poster presenter:  can present a poster and enjoy the benefits of delegate
Remote attendance:  can participate via video presentation or e-poster presentation
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes

Attend Keynote Presentation by world’s most eminent researchers
Access to all the sessions
Get OCM certificate
Get worldwide acknowledgment to your profile and Research
Get your abstracts published with unique DOI in International Journals
Get up to 50% discounts for publishing your entire article in our open access International Journals
Get Handbooks and conference kits
Get an access to the network with eminent personalities from worldwide


To Collaborate Scientific Professionals around the World

Conference Date November 27-28, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Endocrinology & Diabetes Research Journal of Diabetes & Metabolism Pancreatic Disorders & Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by